Related Experiment Video
Updated: Mar 17, 2026

11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
11.3K
Computational Analysis of Differentially Expressed Circulating MicroRNA and Identification of Key Genes in Prostate
Anveshika Manoj1, Shweta Kumari1, Gautam Prasad1
1Department of Biochemistry, King George's Medical University, Lucknow, Uttar Pradesh India.
Indian Journal of Clinical Biochemistry : IJCB
|March 16, 2026
Summary
This study identifies nine microRNAs (miRNAs) and their target genes involved in prostate cancer. Eight of these miRNAs show potential as novel biomarkers for prostate cancer diagnosis and prognosis.
Area of Science:
- Bioinformatics
- Molecular Biology
- Oncology
Background:
- Prostate cancer generates large datasets, including dysregulated microRNAs (miRNAs) in tissues and bodily fluids.
- In silico approaches enhance the accuracy and accessibility of screening dysregulated miRNAs.
Purpose of the Study:
- To identify microRNAs and explore their messenger RNA (mRNA) interactions in prostate cancer development.
- To investigate the potential of identified miRNAs as diagnostic and prognostic biomarkers.
Main Methods:
- Analysis of the GEO dataset GSE112264 using GEO-2R to identify significantly up- and down-regulated miRNAs.
- Targetome analysis to map miRNA-target gene interactions and construct interactive networks.
- Functional enrichment analysis (DAVID 6.8, GSEA) for KEGG, Reactome, and Gene Ontology-Biological Process (GO-BP) pathways.
Main Results:
- Identified 190 significant miRNAs, with 9 miRNAs targeting 20 unique genes crucial for prostate cancer survival and proliferation.
- Discovered two novel miRNAs (miRNA-520a-3p and miRNA-550a-3p) implicated in prostate cancer pathogenesis.
- Highlighted 8 miRNAs with potential for non-invasive diagnostic and prognostic biomarker applications.
Conclusions:
- The identified miRNAs and their target genes offer insights into prostate cancer progression.
- Eight miRNAs warrant further investigation as potential non-invasive biomarkers for prostate cancer.
- Target gene analysis may guide the development of novel therapeutics for prostate cancer management.
Related Concept Videos
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs
24.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K

